New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompare5-Amino-1MQ vs Somatropin (HGH)

5-Amino-1MQ vs Somatropin (HGH)

Side-by-side comparison of key properties, dosing, and research.

Fat Loss & Metabolic
5-Amino-1MQ
Growth Hormone PeptidesAnti-Aging & Longevity
Somatropin (HGH)
Summary
5-Amino-1MQ is a small-molecule NNMT (Nicotinamide N-methyltransferase) inhibitor that raises intracellular NAD+ levels and promotes fat burning. It is notable for targeting adipose tissue directly, reducing fat cell size and number while increasing metabolic rate.
Somatropin is recombinant human growth hormone (rhGH), identical in structure to the 191-amino acid pituitary-derived growth hormone. It is FDA-approved for growth hormone deficiency, short stature, and wasting conditions. Off-label, it is widely explored for body composition, anti-aging, and performance enhancement, though significant risks accompany unsupervised use.
Half-Life
Estimated 4–8 hours
2-3 hours (subcutaneous); 20-30 minutes (intravenous)
Admin Route
Oral
Subcutaneous, Intramuscular (less common)
Research
Typical Dose
50–100 mg
0.15-0.3 mg/day (adults); titrated to IGF-1 levels
Frequency
Once to twice daily
Once daily
Key Benefits
  • Raises intracellular NAD+ levels
  • Directly targets adipose tissue for fat reduction
  • Reduces fat cell size and differentiation
  • Increases basal metabolic rate
  • SIRT1 activation for metabolic regulation
  • No stimulant cardiovascular side effects
  • Synergistic with intermittent fasting and caloric restriction
  • May have anti-aging metabolic benefits
  • Increases lean muscle mass and reduces body fat (particularly visceral)
  • Restores growth hormone deficiency (FDA-approved)
  • Improves bone mineral density
  • Enhances exercise capacity and recovery
  • Supports skin thickness and collagen synthesis
  • Improves lipid profile in GHD patients
  • Explored for anti-aging and cellular regeneration
Side Effects
  • Generally well-tolerated in available studies
  • Mild GI discomfort (rare)
  • Limited long-term human data
  • Fluid retention and edema (common, dose-dependent)
  • Carpal tunnel syndrome
  • Joint and muscle pain
  • Insulin resistance and elevated blood glucose
  • +3 more
Stacks With